
Diabetes is the reference journal for the physiology and pathophysiology of diabetes mellitus. The latest impact factor for Diabetes is 8.261, it is ranked 3rd of 92 publications in the field of endocrinology/metabolism and 2nd among journals publishing original research in that field.
The paper presents results of preclinical research conducted with calcium dobesilate - the active principle of Doxium® by a research team of the AIBILI centre in Coimbra, Portugal in collaboration with OM Pharma... OM Pharma's Press Release -